-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, ST Wanbang (002082.SZ) announced that the new drug WP107, a new drug independently developed by Wanbang Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, to treat systemic myasthenia gravis, has obtained review approval from the Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University/Yuying Children's Hospital Affiliated to Wenzhou Medical University and approved the launch of the project.

Zhitongcaijing·08/18/2026 07:49:05
Listen to the news
Zhitong Finance App News, ST Wanbang (002082.SZ) announced that the new drug WP107, a new drug independently developed by Wanbang Pharmaceutical Group Co., Ltd., a wholly-owned subsidiary of the company, to treat systemic myasthenia gravis, has obtained review approval from the Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University/Yuying Children's Hospital Affiliated to Wenzhou Medical University and approved the launch of the project.